Biodel, Inc.

Biodel, Inc.

Sector: Pharmaceutical Preparations Region: CT, United States

: | Nasdaq: BIOD

Similar to: Hutchison China MediTech Ltd., BioAlliance Pharma SA, United-Guardian, Inc.

Biodel, Inc. is a specialty pharmaceutical company that develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. It is developing novel forms of insulin and other peptide hormones for use in treating diabetes and its complications, including hyperglycemia, hypoglycemia, cardiovascular complications and weight control. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT.

News & Analysis

You may also be interested in: